BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4277102)

  • 21. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y; Kaneko M; Yashima Y; Kumashiro H
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract]   [Full Text] [Related]  

  • 22. The electroencephalogram in cases with Down's syndrome.
    Uoashi T
    Bull Osaka Med Sch; 1970 Apr; 16(1):1-22. PubMed ID: 4248199
    [No Abstract]   [Full Text] [Related]  

  • 23. Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome.
    Coleman M
    Neurology; 1971 Sep; 21(9):911-9. PubMed ID: 4328302
    [No Abstract]   [Full Text] [Related]  

  • 24. Individual variability among children with down's syndrome.
    LaVeck B; Brehm SS
    Ment Retard; 1978 Apr; 16(2):135-7. PubMed ID: 147981
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Improving babies with Down's syndrome.
    White G
    Med J Aust; 1974 Aug; 2(5):184. PubMed ID: 4278643
    [No Abstract]   [Full Text] [Related]  

  • 26. 'Sweet Dreams', 'Happy Days' and elevated 24-h urine 5-hydroxyindoleacetic acid excretion.
    Hallin ML; Mahmoud K; Viswanath A; Gama R
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):80-2. PubMed ID: 23086978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tryptophan-nicotinic acid metabolism in psychiatric diseases].
    Chiancone FM
    Acta Vitaminol Enzymol; 1968; 22(3):111-33. PubMed ID: 4239848
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychomotor development of children with Down's syndrome after administration of Encephabol and intense rehabilitation by the parents].
    Habináková E; Bimková Z; Cernay J
    Cesk Pediatr; 1976 Apr; 31(4):220-2. PubMed ID: 132300
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cerebral and peripheral consumption of L-5-HTP in patients with manic, depressive or psychotic syndromes].
    Gaillard JM; Eisenring JJ; Tissot R
    Encephale; 1973; 62(5):395-407. PubMed ID: 4546593
    [No Abstract]   [Full Text] [Related]  

  • 31. Mental development of infants with Down's syndrome.
    Dicks-Mireaux MJ
    Am J Ment Defic; 1972 Jul; 77(1):26-32. PubMed ID: 4262235
    [No Abstract]   [Full Text] [Related]  

  • 32. [Correlation of the clinical and pharmaco-dynamic effects of Niamid in the treatment of severely mentally retarded children].
    Bettschart W; Broché JP; Tissot R
    Ann Paediatr; 1965; 205(3):216-33. PubMed ID: 4221631
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
    Airaksinen EM
    J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of language, abstraction, and numerical concept formation in Down's syndrome children.
    Cornwell AC
    Am J Ment Defic; 1974 Sep; 79(2):179-90. PubMed ID: 4278053
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of Down's syndrome].
    Iida M
    Saishin Igaku; 1968 Feb; 24(2):345-9. PubMed ID: 4239285
    [No Abstract]   [Full Text] [Related]  

  • 36. [Development of children with Down's syndrome].
    Cernay J; Hudáková G
    Cesk Pediatr; 1976 Aug; 31(8):453-8. PubMed ID: 135651
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of children with Down's Syndrome.
    Griffiths MI
    Physiotherapy; 1976 Jan; 62(1):11-5. PubMed ID: 130642
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of personality formation of children affected with Down's syndrome].
    Nakauchi M
    Seishin Shinkeigaku Zasshi; 1972 Feb; 74(2):79-97. PubMed ID: 4265535
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-hydroxyindoles in phenylketonuric and nonphenylketonuric mental defectives.
    Pare CM
    Adv Pharmacol (1962); 1968; 6(Pt B):159-65. PubMed ID: 4232127
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.
    Bazelon M; Paine RS; Coeiw VA; Hunt P; Houck JC; Mahanand D
    Lancet; 1967 May; 1(7500):1130-3. PubMed ID: 4164790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.